Comparative Pharmacology
Head-to-head clinical analysis: NICORETTE versus NICOTROL.
Peer-Reviewed Evidence
Head-to-head clinical analysis: NICORETTE versus NICOTROL.
NICORETTE vs NICOTROL
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Nicotine acts as an agonist at nicotinic acetylcholine receptors, stimulating the release of neurotransmitters such as dopamine and norepinephrine, which reduces withdrawal symptoms and cravings associated with smoking cessation.
Nicotine is a nicotinic acetylcholine receptor agonist. It binds to and activates nicotinic acetylcholine receptors in the brain, leading to dopamine release and other neurotransmitter effects that mediate nicotine dependence and withdrawal symptoms.
Nicotine replacement therapy. For smoking cessation, chewing gum: 2 mg or 4 mg piece chewed slowly for 30 minutes every 1-2 hours as needed, maximum 24 pieces/day. Transdermal patch: Apply one 7 mg, 14 mg, or 21 mg/24 hour patch daily. Lozenge: 2 mg or 4 mg lozenge dissolved in mouth every 1-2 hours, maximum 20 lozenges/day. Inhaler: 6-16 cartridges/day. Nasal spray: 1-2 doses/hour, maximum 40 doses/day. All routes: typical duration 8-12 weeks.
Inhalation: 1 cartridge (4 mg) inhaled as needed for craving relief, up to 16 cartridges per day; typical initial dose: 4-8 cartridges per day, with weaning over 12 weeks.
None Documented
None Documented
The terminal elimination half-life of nicotine is approximately 2 hours. This short half-life necessitates frequent dosing or continuous delivery to maintain therapeutic levels. Cotinine, the major metabolite, has a half-life of 15-20 hours.
2 hours (range 1-4 h). Shorter in smokers due to induction of metabolism; prolonged in renal impairment.
Nicotine is extensively metabolized in the liver, primarily to cotinine. Renal excretion accounts for 2-35% of nicotine elimination unchanged, depending on urine pH (acidic urine increases excretion). Biliary/fecal excretion is minimal (<5%). Total clearance is about 1 L/min, with renal clearance of about 100 mL/min.
Primarily renal (10-20% unchanged; 80-90% as metabolites, mainly cotinine and nicotine-N'-oxide). Biliary/fecal excretion accounts for <10%.
Category C
Category C
Smoking cessation aid
Smoking cessation aid